Idexx Laboratories Inc (IDXX): Share Repurchases
$1.22B
Year ended 2025-12-31
$1.18B
Trailing 12 months to 2026-06-30
+14.1%
3-year compound annual growth
+46.1%
5-year compound annual growth
+11.7%
10-year compound annual growth
| Period ended | Share Repurchases | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.22B | +45.4% | 2026-02-20, From 2025-01-01 |
| 2024-12-31 | $837.03M | n/m | 2026-02-20, From 2024-01-01 |
| 2023-12-31 | $71.92M | -91.2% | 2026-02-20, From 2023-01-01 |
| 2022-12-31 | $819.71M | +9.8% | 2025-02-21, From 2022-01-01 |
| 2021-12-31 | $746.78M | +308.5% | 2024-02-22, From 2021-01-01 |
| 2020-12-31 | $182.81M | -39.4% | 2023-02-16, From 2020-01-01 |
| 2019-12-31 | $301.66M | -18.3% | 2022-02-16, From 2019-01-01 |
| 2018-12-31 | $369.32M | +30.7% | 2021-02-12, From 2018-01-01 |
| 2017-12-31 | $282.56M | -7.1% | 2020-02-14, From 2017-01-01 |
| 2016-12-31 | $304.09M | -24.4% | 2019-02-15, From 2016-01-01 |
| 2015-12-31 | $401.98M | -35.0% | 2018-02-16, From 2015-01-01 |
| 2014-12-31 | $618.16M | +68.1% | 2017-02-17, From 2014-01-01 |
| 2013-12-31 | $367.76M | +178.0% | 2016-02-17, From 2013-01-01 |
| 2012-12-31 | $132.27M | -48.2% | 2015-02-17, From 2012-01-01 |
| 2011-12-31 | $255.50M | +78.6% | 2014-02-18, From 2011-01-01 |
| 2010-12-31 | $143.09M | +72.2% | 2013-02-19, From 2010-01-01 |
| 2009-12-31 | $83.10M | -37.2% | 2012-02-17, From 2009-01-01 |
| 2008-12-31 | $132.34M | n/a | 2011-02-22, From 2008-01-01 |
Share Repurchases at similar companies
| Company | Year ended | Share Repurchases | Change YoY |
|---|---|---|---|
| Idexx Laboratories Inc (IDXX) | 2025-12-31 | $1.22B | +45.4% |
| QuidelOrtho Corp (QDEL) | 2025-12-28 | $0 | n/a |
| Lantheus Holdings, Inc. (LNTH) | 2025-12-31 | $300.02M | +200.0% |
| Volitionrx Ltd (VNRX) | 2024-12-31 | $0 | -100.0% |
Compare IDXX, QDEL, LNTH, VNRX side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗